Stocktoria

Medinotec Inc. MDNC

OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2023-03-21

Medinotec Inc. statistics & valuation

P / E74.0×
P / S6.0×
P / B10.3×
P / FCF61.8×
Net margin8.2%
FCF margin9.8%
Return on capital19.2%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-35.30% -8.10% 23.70% 8.20% 2023202420252026
Gross margin (%)
58.20% 48.70% 52.90% 52.70% 2023202420252026
Operating margin (%)
-23.90% 12.00% 35.00% 11.20% 2023202420252026
Return on equity (%)
-13.80% -18.70% 50.60% 13.90% 2023202420252026
Shares outstanding
11734 11.7M 11.7M 11.8M 2023202420252026
Net debt ($)
2023202420252026
Share buybacks ($)
2023202420252026
Return on assets (%)
-7.90% -8.40% 31.70% 11.70% 2023202420252026
Free cash flow margin (%)
-54.60% 2.00% 11.60% 9.80% 2023202420252026
Debt / equity (×)
2023202420252026
EPS ($)
2023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023
Gross margin52.7%52.9%48.7%58.2%
Operating margin11.2%35.0%12.0%-23.9%
Net margin8.2%23.7%-8.1%-35.3%
FCF margin9.8%11.6%2.0%-54.6%
Return on assets11.7%31.7%-8.4%-7.9%
Return on equity13.9%50.6%-18.7%-13.8%
Current ratio5.834.275.2947.25

Computed from company filings · US · as of 2026-02-28. Facts plus Stocktoria's own computed scores — not investment advice.